.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Valeant Luxembourg Company Profile

« Back to Dashboard

Summary for Applicant: Valeant Luxembourg

Patents:5
Tradenames:4
Ingredients:5
NDAs:6
Drug Master File Entries: (click here to view)4
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Luxembourg
TARGRETIN
bexarotene
CAPSULE;ORAL021055-001Dec 29, 1999RXYes<disabled><disabled>
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119-001Apr 12, 2000RXYes5,756,541<disabled> <disabled>
Valeant Luxembourg
TARGRETIN
bexarotene
GEL;TOPICAL021056-001Jun 28, 2000RXYes5,962,731<disabled> <disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc